Moffitt Cancer Center | Strategic Alliance Partners

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 53 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,800 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

Latest from Moffitt Cancer Center

Study Results May Change Treatment Standard for Patients Receiving Transplants From Unrelated Donors

December 21, 2012

Article

Patients receiving transplants from unrelated donors to treat various hematologic malignancies may benefit more from receiving adult stem cells harvested from bone marrow rather than peripheral-blood stem cells (the current standard).

Five MEK-Related Questions for Jeffrey S. Weber, MD, PhD

October 12, 2012

Article

Jeffrey S. Weber, MD, PhD, specializes in cancer immunotherapy and has been involved in numerous trials of clinical drug development, vaccines, and studies on autoimmunity and melanoma.

Targeted PD-1 Therapy Offers Opportunity to Sequence Agents

August 30, 2012

Article

Drugs that target the programmed death-1 pathway hold considerable promise for the treatment of patients with melanoma, particularly in integrating the agents into the sequence of therapy.

Paul Jacobsen Discusses Survivorship Care Plans

August 10, 2012

Video

Paul Jacobsen, from the H. Lee Moffitt Cancer Center and Research Institute, Discusses Survivorship Care Plans

Moffitt Cancer Center: Cutting-Edge, Total Cancer Care

May 09, 2012

Article

Located in Tampa, Florida, Moffitt Cancer Center enjoys a reputation as one of the world's most sophisticated cancer centers.

Immunotherapy and Radiation Provide Good Tumor Response in Sarcoma Patients

April 16, 2012

Article

A combination of immunotherapy and fractionated external-beam radiation therapy provided tumor-specific immune responses in patients with soft-tissue sarcoma.